Trial NCT00003552

View at ClinicalTrials.gov 
Aliases: NCT00001739
Org. Study IDs: CDR0000066609
Secondary IDs: NHLBI-98-H-0006

Last trial update was posted on 2024-03-04

MeSH Interventions

Antilymphocyte Serum Cyclophosphamide Fludarabine

MeSH Conditions

Melanoma

Other Conditions

Recurrent Melanoma Stage IV Melanoma

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID